Abstract:Objectve To investigate the effect of resveratrol on the proliferation of glioblastoma resistant to temozolamine (TMZ) and the relationship between cell cycle and drug resistance genes expression.Methods U87 cell line was adopted to induce TMZ glioma model (U87-TMZ) by increasing the concentration of temozolomide.Methyl thiazol tetrazolium (MTW) assay was used to detect the proliferation of drug-resistant cell lines.Flow cytometry was used to detect the change of U87-TMZ cell cycle by resveratrol.Western blotting was used to detect the expression of Cyclin D1,topoisomerase (TOPO Ⅱ) α,glutathione-s-transferase (GST)-π,O6-methylguanine-DNA-methyltransferase (MGMT),and P-glycoprotein (P-gp).Results U87 glioma cells were stably stimulated with 20 μg/ml temozolamine for 6 months,and the U87-TMZ model was successfully constructed.Compared with the control group (DMSO group) and the blank group,the inhibition of proliferation of glioma cells was significantly decreased in 24 h in U87-TMZ model treated with 40 μg/ml resveratrol (experimental group) (P =0.014).Resveratrol inhibited the U87-TMZ cell cycle in a different period as compared with the control group,resulting in prolongation of the G1 phase and a decrease in the division phase.Western blotting analysis showed that resveratrol had different expression of drug resistance genes.The expression of Cyclin D1,TOPO Ⅱ α,GST-π and MGMT proteins was significantly decreased in U87-TMZ group (experimental group) as compared with U87 group (P =0.002,0.007,0.031).Before and after treatment with resveratrol in the U87-TMZ group (experimental group),the expression of P-gp gene was not significantly different (P =1.043).The content of Cyclin D protein in U87-TMZ group was related to the change of resveratrol resistance genes.After up-regulating the expression of Cyclin D,the expression of TOPO Ⅱ α,GST-π,MGMT and P-gp was statistically significantly increased (P =0.001).Conclusion Resveratrol inhibits tumor cell proliferation by affecting the expression of Cyclin D protein and regulating U87-TMZ cell cycle.The mechanism may be related to the reduction of the sensitivity of the drug resistance of TOPO Ⅱ α,GST-π and MGMT gene expression.

Effect of p53 targeting small molecule RITA combined with temozolomide on the growth of glioma cells in vitro

Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma

Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists

Enhanced Proliferation Inhibition and Apoptosis in Glioma Cells Elicited by Combination of Irinotecan and Imatinib

P53 Upregulated Modulator of Apoptosis Sensitizes Drug-Resistant U251 Glioblastoma Stem Cells to Temozolomide Through Enhanced Apoptosis.

Combining dichloroacetate with temozolomide increases the antitumor efficacy of temozolomide by inhibiting HIF-1α and promoting p53 signaling pathway

PI3K Inhibitor Combined with Mir-125B Inhibitor Sensitize TMZ-induced Anti-Glioma Stem Cancer Effects Through Inactivation of Wnt/β-catenin Signaling Pathway

Effects of new alkylating agent temozolomide easter on the proliferation of glioma cells

Down‐Regulation of AQP4 Expression Via P38 MAPK Signaling in Temozolomide‐Induced Glioma Cells Growth Inhibition and Invasion Impairment

Effect of Resveratrol on Proliferation of Telmozolamine Resistant Glioblastoma and Mechanism

Pyrrolidine Dithiocarbamate Sensitizes U251 Brain Glioma Cells to Temozolomide Via Downregulation of MGMT and BCL-XL

Decreased DNA Damage and Improved P53 Specificity of RITA Analogs

IFN-α/β Enhance Temozolomide Cytotoxic Activity Against Human Glioma in vivo

Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

Glioma Targeting Peptide in Combination with the P53 C Terminus Inhibits Glioma Cell Proliferation in Vitro

Synergistic inhibition of human glioma cell line by temozolomide and PAMAM-mediated miR-21i

GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment

IDH1-mutant metabolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT

Temozolomide in Combination with Metformin Act Synergistically to Inhibit Proliferation and Expansion of Glioma Stem-Like Cells

The clinical observation of temozolomide combined with intensity-modulated radiotherapy in the treatment of malignant glioma with positive MGMT

Sequence-Dependent Synergistic Inhibition Of Human Glioma Cell Lines By Combined Temozolomide And Mir-21 Inhibitor Gene Therapy